View Older Stories View More Recent Stories

Nov 6, 2025 07:03AM Opus Genetics advances LCA5 gene therapy toward pivotal trial after FDA meeting
Nov 6, 2025 07:01AM Opus Genetics raises $23 million in registered direct offering
Nov 6, 2025 07:00AM Opus Genetics Announces $23 Million Registered Direct Offering
Nov 6, 2025 07:00AM Opus Genetics Announces Successful FDA Meeting Supporting Advancement of OPGx-LCA5 Toward Pivotal Trial for LCA5-Related Inherited Retinal Disease
Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering
Oct 23, 2025 07:20AM Tango Therapeutics Announces $225 Million Financing
Oct 21, 2025 09:00AM Expedia Group names Rob Bevegni as VP of investor relations
Oct 21, 2025 09:00AM Expedia Group Appoints Rob Bevegni as Vice President of Investor Relations
Oct 21, 2025 08:00AM Minerva Neurosciences secures up to $200 million for schizophrenia drug trial
Oct 21, 2025 08:00AM Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and R
Oct 20, 2025 04:05PM Lexeo Therapeutics closes $153.8 million public offering and private placement
Oct 20, 2025 04:05PM Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
Oct 16, 2025 11:30PM Lexeo Therapeutics prices $135 million public offering at $8 per share
Oct 16, 2025 11:29PM Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
Oct 16, 2025 04:32PM Lexeo Therapeutics launches stock offering and private placement
Oct 16, 2025 04:32PM Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
Oct 3, 2025 05:19PM Factbox-How hedge funds performed in September
Oct 3, 2025 07:05AM Ovid Therapeutics raises up to $175 million in private placement
Oct 3, 2025 07:05AM Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
Sep 10, 2025 09:17AM Howard Cheng Joins Carrick Lane as Partner and Head of Risk
Sep 10, 2025 07:00AM CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
Sep 10, 2025 07:00AM CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
Sep 10, 2025 07:00AM CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Sep 4, 2025 09:23AM ADFW 2025: World's Financial Elite Managing Over USD 60 Trillion to Explore How Technology is Shaping Finance
Aug 25, 2025 07:00AM iBio closes $50 million public offering led by Balyasny
Aug 25, 2025 07:00AM iBio Announces Closing of $50 Million Public Offering
Aug 14, 2025 06:56AM Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2025 06:41AM Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2025 06:18AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2025 06:18AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2025 06:12AM Form SCHEDULE 13G Camping World Holdings, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2025 06:09AM Form SCHEDULE 13G Spirit AeroSystems Holdi Filed by: BALYASNY ASSET MANAGEMENT L.P.
Jul 9, 2025 09:00AM Silicon Valley Defense Group Names Virtualitics to NatSec100 List for Mission-Critical AI Innovation
May 27, 2025 12:35PM F.N.B. Corp's (FNB) First National Bank names Chris Chan as CSO
May 27, 2025 12:30PM FNB Appoints Christopher Chan as Chief Strategy Officer
May 15, 2025 06:14AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2025 06:12AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2025 06:12AM Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2025 06:12AM Form SCHEDULE 13G/A Hudson Pacific Propertie Filed by: BALYASNY ASSET MANAGEMENT L.P.
Apr 14, 2025 10:00AM Centri Announces Final Schedule for Capital Conference at Nasdaq on April 22
Apr 2, 2025 08:04AM March hedge fund stock selloff buoys some, costs others, sources say
Mar 19, 2025 04:33PM StandardAero (SARO) appoints Rama Bondada as VP of Investor Relations
Mar 19, 2025 04:30PM StandardAero Appoints Rama Bondada to Vice President, Investor Relations
Feb 25, 2025 08:02AM Senti Biosciences (SNTI) Strengthens Leadership Team with Strategic Hires
Feb 25, 2025 08:00AM Senti Bio Strengthens Leadership Team with Strategic Hires
Feb 14, 2025 07:28AM Form SCHEDULE 13G Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 14, 2025 06:22AM Form SCHEDULE 13G/A LEAP THERAPEUTICS, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 14, 2025 06:08AM Form SCHEDULE 13G Hudson Pacific Propertie Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 14, 2025 06:06AM Form SCHEDULE 13G Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 14, 2025 06:05AM Form SCHEDULE 13G/A Shapeways Holdings, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
View More Recent Stories View Older Stories